These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15027921)

  • 21. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy.
    Parliament M; Alidrisi M; Munroe M; Wolfaardt J; Scrimger R; Thompson H; Field C; Kurien E; Hanson J
    Int J Oral Maxillofac Surg; 2005 Mar; 34(2):114-21. PubMed ID: 15695037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
    Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
    Kwong DL; Pow EH; Sham JS; McMillan AS; Leung LH; Leung WK; Chua DT; Cheng AC; Wu PM; Au GK
    Cancer; 2004 Oct; 101(7):1584-93. PubMed ID: 15378492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
    Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.
    Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy.
    Liu WS; Lee SP; Lee JK; Su MC; Chen GD; Lee HS; Lee H
    Jpn J Clin Oncol; 2006 Oct; 36(10):626-31. PubMed ID: 17008345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.
    Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
    Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
    Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.
    McMillan AS; Pow EH; Kwong DL; Wong MC; Sham JS; Leung LH; Leung WK
    Head Neck; 2006 Aug; 28(8):712-22. PubMed ID: 16475203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
    Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
    Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiotherapy for head and neck cancer.
    Caglar HB; Allen AM
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):425-31. PubMed ID: 17679916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.